Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a non-coding RNA transcript that is antisense to the RXRG (Retinoid X receptor gamma) gene. There is no evidence this transcript encodes a protein or acts as a recognized molecular target in pharmacology. It is not classified as a receptor, enzyme, transporter, or other canonical drug target. The function, disease relevance, and potential as a biomarker or therapeutic target are unknown at this time. The RXRG gene itself encodes a nuclear receptor involved in transcriptional regulation and cell differentiation, but "novel transcript, antisense to RXRG" is distinct and should not be confused with RXRG or its protein product[1][7].
None established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to RXRG (ENSG00000298458).